Objectives Ambulatory blood pressure measurement (ABPM), although recommended for the diagnosis and management of hypertension, has limited availability. The objective of this study was to show that if the characteristics of patients attending pharmacies for ABPM are similar to those attending primary care, the technique can be made more widely available to patients through pharmacies.
Introduction
The global prevalence of hypertension in adults aged 25 years and older in 2008 was around 40% [1] . Complications of hypertension are associated with an estimated 9.4 million deaths worldwide every year [2] . Hypertension, which affects B50 million individuals in the USA, is the most common primary diagnosis in America, with an estimated 35 million office visits to primary care physicians [3] . In the UK, B12% of primary care consultations are for hypertension and B£1 billion is spent on blood pressure (BP)-lowering drugs annually [4] . Because of the superiority of ambulatory blood pressure measurement (ABPM) over both clinic BP measurement and home BP measurement, the National Institute for Clinical Excellence (NICE) in the UK has recommended that any individual who has had an elevated BP with conventional measurement should be offered ABPM to confirm the presence or absence of sustained hypertension [4] . The recently published Position Paper on ABPM from the European Society of Hypertension also advocates wider availability of ABPM [5] . NICE has shown that ABPM is more cost-effective than either conventional BP or selfmeasurement of BP [4, 6] . If ABPM was widely available, the diagnosis and treatment of hypertension would be improved. Failure to identify white-coat hypertension can lead to inappropriate treatment in normotensive patients and similarly, hypertensive individuals who show a white-coat effect may receive inappropriate dose titrations or additional antihypertensive agents. Identification of patients with white-coat hypertension would result, therefore, in large financial savings because of reduced prescribing of drugs [4] .
Although recommendations for ABPM may be scientifically and fiscally sound, in reality, the technique is not available in primary care, hospital or specialist clinics in sufficient quantity to provide ABPM to all patients with hypertension. It is important, therefore, to examine ways of making ABPM more widely accessible to a substantial proportion of the adult population.
The dabl primary care module, which has been in use in primary care in Ireland for many years, has been modified for use in pharmacies. In this paper, the ABPM data from individuals having ABPM performed in pharmacies are compared with the ABPM data from primary care. To our knowledge, this is the first report of ABPM data from patients attending pharmacies.
Patients and methods

Primary care patients
Patients referred for ABPM in primary care practices because of an elevated office BP measurement, and whose data were hosted on the dabl system (dabl Ltd, Dublin, Ireland), were used to compare with the data from pharmacies.
Pharmacy patients
ABPM recordings, performed in pharmacies in a number of towns in Ireland in patients who had hypertension, or who suspected they might have hypertension, and whose data were hosted on the dabl system, were analysed. The treatment status of patients in both primary care and pharmacies was unknown. [7, 8] . Daytime was defined as 9 a.m-9 p.m. and night-time from 1 a.m. to 6 a.m. [9] . Measurements were recorded at 30-min intervals over the full 24 h. The monitor was initialized by the pharmacist or primary care user by connecting it to a computer and following a simple set of instructions. When the 24-h recording was completed, the patient returned with the monitor, which was connected to a computer that loaded the data to the dabl system for central hosting and analysis. The results were then transmitted to the pharmacy or primary care computer for immediate printing.
Ambulatory blood pressure measurement program
The dabl software program for primary care has been described previously [10, 11] . This system provides a succinct one-page report with standardized presentation, summary statistics, including maximum BP in the whitecoat window and average BPs in the daytime and night-time windows, together with the individual BP measurements, a plot of data and an interpretative report (which has been validated for accuracy against expert observers [12] ). This software program has been modified for use in pharmacies so as to provide the same information, but with all operational options fixed to facilitate use and the need for minimal instruction. A printout of the results, with a plot and interpretative report, is given to the patient by the pharmacist. If the report is normal, the patient is instructed to bring it to the general practitioner at the next visit, but if it is abnormal, the patient is advised to arrange an early appointment.
Data analysis
Data from each ABPM consisted of the first measurement, mean daytime BP, mean night-time BP, the day of the week on which it was recorded and the time of first measurement. Patients who did not have these data were excluded.
Patients were classed by their mean BP as having hypertension, normotension or white-coat hypertension. Hypertension was defined as a mean daytime systolic blood pressure (SBP) of at least 135 mmHg or a mean daytime diastolic blood pressure (DBP) of at least 85 mmHg; white-coat hypertension was defined as a normal mean daytime BP with a first ABPM systolic BP measurement of at least 140 mmHg or a mean diastolic BP of at least 90 mmHg. All other individuals were defined as normotensive.
The nocturnal dip was calculated as the percentage decrease in the mean BP from daytime to night-time. A patient was defined as a dipper if the percentage decrease in the mean pressure from daytime to nighttime was at least 10% for SBP or for DBP and a nondipper if this fall was not present.
The days of the week, on which the ABPM was performed, were paired into Monday or Tuesday, Wednesday or Thursday, and Friday or Saturday. Eighty-eight patients, who had an ABPM performed on a Sunday, in a pharmacy, were excluded from this analysis.
The time of the first measurements was classed as 07:00-08:59 (early morning), 09:00-12:59 (mid morning), 13:00-17:59 (afternoon) and 18:00-21:00 (evening). One-hundred primary care ABPMs, with times outside these periods, were excluded as it is likely that these were because of exceptional circumstances or a PC with an incorrect time.
The BP classification, dipping classification, day of the week and time of day were compared for primary care and pharmacy patients and sex with crosstabs and w 2 , or Fisher's exact test, analysis. The first ABPM measurement, mean daytime BP, mean night-time BP and the nocturnal dip were analysed for source and sex using analysis of variance, with Duncan post-hoc tests to compare groups along with a t-test for source comparison.
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Analysis was carried out using the SPSS 10.0 (SPSS Inc., Chicago, Illinois, USA).
Ethical approval for the study was provided by the Connolly Hospital research ethics committee (January 2012). All participants provided informed consent before taking part in the study. Data were anonymized before database extraction in accordance with data protection legislation and approved by the local ethics committee.
Results
Baseline characteristics
A total of 46 978 ABPMs recorded in the primary care and 1698 ABPMs recorded in pharmacies between 2007 and 2013 were available for analysis. Fifty-three percent of all patients were women, and the mean age was 57.9 years, with the pharmacy patients being slightly younger than those in primary care. Baseline characteristics for the first ABPM measurement, for pressures in the daytime window (09:00-21:00), the night-time window (01:00-06:00) and for the nocturnal dip are shown in Table 1 .
Mean pressures in all categories, except for SBP recorded in primary care, were higher in men. There were no differences between the sources of the ABPM, except for the first measurement, where slightly higher values in the pharmacy ABPM (150.8±19.5/88.7±13.7 vs. 149.6± 20.7/88.0±14.4 mmHg for primary care) reached statistical significance because of the number of patients.
Ambulatory blood pressure measurement profiles ABPM profiles for both the primary care and pharmacy patients are shown in 
Timing of ambulatory blood pressure measurement
The availability of ABPM differed between primary care and pharmacy (Tables 3 and 4) . A preference for having ABPM on Fridays and Saturdays was evident in pharmacies (19.6 vs. 6.6% for primary care), whereas there was a preference for early morning recording in primary care (4.1 vs. 1.1% for pharmacy).
Discussion
To the best of our knowledge, this study is the first of its kind to report on ABPM data collected in pharmacies. There is worldwide agreement that ABPM is indicated for the exclusion or confirmation of suspected white-coat hypertension [5, 13] . The NICE guideline published in 2011 has generated considerable comment for recommending ABPM in anyone suspected of having hypertension. What makes the NICE guideline different from other international guidelines is that for the first time, it is stated unequivocally that ABPM should be offered to anyone suspected of having hypertension by virtue of having had an elevated conventional BP measurement [4] . NICE has estimated that the use of ABPM could save the NHS around £10 million (h12.6 million) after 5 years by reducing the number of consultations and by detecting white-coat hypertension, so that drugs are only prescribed to those patients with sustained hypertension. If primary care practices were to provide ABPM, it is estimated that the initial cost would be around £1016 (h1280) to purchase devices with a further investment of around £380 (h479) a year per device for upkeep [4] .
With increasing longevity, the prevalence of hypertension is growing and there is a need to provide ABPM for large numbers of individuals in all countries across the world [5] . It is evident that the demand for ABPM cannot be provided solely in primary care and alternative ways for providing patients with the technique must be explored. The results of this study show that it is feasible for patients with hypertension to attend a local pharmacy for ABPM and that these patients are very similar to those attending a primary care practice for the investigation [14] .
Pharmacists are being increasingly recognized as playing an important role in healthcare delivery and particularly in improving BP control. The movement to involve pharmacists in the management of hypertension is particularly strong in the USA [15] [16] [17] [18] [19] [20] , with, for example, a suggestion that the country's 300 000 pharmacists should become a collaborative force in healthcare delivery [21] .
Our study shows that BP levels in pharmacies overall follow an expected pattern, with those for men being generally higher than women. However, there were no consistent differences between ABPM recorded in pharmacies and in primary care. Similarly, the incidences of white-coat hypertension and nocturnal dipping were broadly similar. The large sample sizes meant that small differences reach statistical significance. The main differences between the two settings were in the availability of ABPM in a local and convenient pharmacy rather than having to attend a general practitioner or specialist clinic. In particular, the availability of having ABPMs on Fridays and Saturdays in pharmacies was popular as most GPs do not provide this facility simply because ABPM initiated on Fridays must be removed on Saturdays when primary care practices are closed. The opening times of pharmacies, especially availability on Saturdays, was popular with patients. The availability of an evening service in pharmacies was also preferred whereas the early morning service provided in some primary care practices, but not readily available in pharmacies, may have facilitated patients on their way to work.
An unexpected aspect of the pharmacy service was that giving an interpretative report of the ABPM to the patient involved the patient in the management process, with the possibility of improving compliance to medication and management.
The expansion of ABPM access in accordance with international guidelines will be challenging in the short to medium term and if the technique is to be made widely available to patients with hypertension, alternative providers to primary care and specialist clinics will have to be enlisted. Our study shows that pharmacies are a readily available provider for ABPM and that the characteristics of patients attending a pharmacist and the results obtained with ABPM do not differ from those attending primary care [22] . This comparison is important because the different referral processes in primary care and pharmacies could have influenced the prevalence of white-coat hypertension.
If this was to have been the case, the main indication for ABPM as recommended by NICE, namely the substantial financial savings from less drug prescribing, would no longer have been valid. The presence of white-coat hypertension in over 20% of patients attending for ABPM in primary care and in pharmacies shows that as many patients attending pharmacies for ABPM will be identified as having whitecoat hypertension as those attending primary care, and that in both settings, considerable savings will result from reduced prescribing of BP-lowering drugs. 
